HKD 1.32
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -385.03 Million CNY | 6.19% |
2022 | -410.45 Million CNY | 80.77% |
2021 | -2.13 Billion CNY | -192.91% |
2020 | -728.63 Million CNY | -489.23% |
2019 | -123.66 Million CNY | -235.29% |
2018 | -36.88 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -37.9 Million CNY | 0.0% |
2024 Q1 | -37.9 Million CNY | 49.89% |
2023 Q3 | -75.63 Million CNY | 35.3% |
2023 FY | -385.03 Million CNY | 6.19% |
2023 Q4 | -75.63 Million CNY | 0.0% |
2023 Q2 | -116.88 Million CNY | 0.0% |
2023 Q1 | -116.88 Million CNY | 5.08% |
2022 Q3 | -123.14 Million CNY | -52.95% |
2022 Q2 | -80.51 Million CNY | 0.0% |
2022 Q1 | -80.51 Million CNY | -13.3% |
2022 FY | -410.45 Million CNY | 80.77% |
2022 Q4 | -123.14 Million CNY | 0.0% |
2021 Q1 | -993.82 Million CNY | -555.98% |
2021 Q2 | -993.82 Million CNY | 0.0% |
2021 Q4 | -71.06 Million CNY | 0.0% |
2021 Q3 | -71.06 Million CNY | 92.85% |
2021 FY | -2.13 Billion CNY | -192.91% |
2020 Q4 | -151.5 Million CNY | 0.0% |
2020 Q1 | -33.27 Million CNY | -4.2% |
2020 Q2 | -33.27 Million CNY | 0.0% |
2020 FY | -728.63 Million CNY | -489.23% |
2019 FY | -123.66 Million CNY | -235.29% |
2019 Q4 | -31.93 Million CNY | 0.0% |
2018 FY | -36.88 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 643.256% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 2332.104% |